Facet browsing currently unavailable
Page 10 of 2295 results
Sort by: relevance publication year
Hypoglycemia in patients with type 2 diabetes using concomitant exenatide BID and long-acting insulin therapy JOURNAL ARTICLE published January 2011 in Journal of Medical Economics |
Clinical outcome of hypertension management JOURNAL ARTICLE published January 2008 in Journal of Medical Economics |
Economic impact of expanded use of biologic therapy for the treatment of rheumatoid arthritis and Crohn’s disease in Argentina, Brazil, Colombia, and Mexico JOURNAL ARTICLE published 1 December 2016 in Journal of Medical Economics |
Cost effectiveness of atazanavir-ritonavir versus lopinavir-ritonavir in treatment-naïve human immunodeficiency virus-infected patients in the United States JOURNAL ARTICLE published January 2011 in Journal of Medical Economics |
Drug usage patterns and treatment costs in newly-diagnosed type 2 diabetes mellitus cases, 2007 vs 2012: findings from a large US healthcare claims database analysis JOURNAL ARTICLE published 2 July 2016 in Journal of Medical Economics |
Estimated cost savings associated with the use of valsartan in heart failure in a large US health plan JOURNAL ARTICLE published January 2007 in Journal of Medical Economics |
Clinical and economic benefits of professional CGM among people with type 2 diabetes in the United States: analysis of claims and lab data JOURNAL ARTICLE published 4 March 2018 in Journal of Medical Economics |
Annual patient and caregiver burden of oncology clinic visits for granulocyte-colony stimulating factor therapy in the US JOURNAL ARTICLE published 3 May 2016 in Journal of Medical Economics |
Updated trends in US brand-name and generic drug competition JOURNAL ARTICLE published 1 September 2016 in Journal of Medical Economics Research funded by Pharmaceutical Research and Manufacturers of America Foundation (N/A (see 3rd party support disclosure)) |
Health and economic impact of PHiD-CV in Canada and the UK: a Markov modelling exercise JOURNAL ARTICLE published January 2012 in Journal of Medical Economics |
Comparison of second-generation antipsychotic treatment on psychiatric hospitalization in Medicaid beneficiaries with bipolar disorder JOURNAL ARTICLE published January 2011 in Journal of Medical Economics |
Validity and measurement equivalence of EQ-5D-5L questionnaire among heart failure patients in Malaysia: a cohort study JOURNAL ARTICLE published 31 December 2024 in Journal of Medical Economics |
Switching of biologic disease modifying anti-rheumatic drugs in patients with rheumatoid arthritis in a real world setting JOURNAL ARTICLE published April 2014 in Journal of Medical Economics |
Time since diagnosis, treatment pathways and current pain status: a retrospective assessment in a back pain population JOURNAL ARTICLE published May 2013 in Journal of Medical Economics |
A new model to evaluate the long-term cost effectiveness of orphan and highly specialised drugs following listing on the Australian Pharmaceutical Benefits Scheme: the Bosentan Patient Registry JOURNAL ARTICLE published January 2008 in Journal of Medical Economics |
Relationship between incidence of fracture and health-related quality-of-life in metastatic breast cancer patients with bone metastases JOURNAL ARTICLE published February 2013 in Journal of Medical Economics |
Budget impact analysis of adjunctive therapy with lacosamide for partial-onset epileptic seizures in Belgium JOURNAL ARTICLE published January 2011 in Journal of Medical Economics |
Indirect comparisons of relative efficacy estimates of zuranolone and selective serotonin reuptake inhibitors for postpartum depression JOURNAL ARTICLE published 31 December 2024 in Journal of Medical Economics |
Economic value and cost-effectiveness of biventricular versus right ventricular pacing: results from the BLOCK-HF study JOURNAL ARTICLE published 3 October 2019 in Journal of Medical Economics |
Predictors of high healthcare resource utilization and liver disease progression among patients with chronic hepatitis C JOURNAL ARTICLE published 2 April 2016 in Journal of Medical Economics |